Medline (MDLN) Price to Sales (2026)
Medline's (MDLN) quarterly Price to Sales came in at 6.65 in Q2 2026, down 10.04% quarter-over-quarter from 7.39 in Q1 2026.
Powered by 
Analysis
Medline (MDLN) Price to Sales (2026) Analysis & Trends
Medline (MDLN) has reported Price to Sales for 1 consecutive years, with 6.65 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to Sales changed N/A year-over-year to 6.65 in Q2 2026; TTM through Jun 2026 was 1.79, a N/A change from a year earlier, with the FY2025 full-year figure at 1.94, changed N/A from the prior year.
- Price to Sales was 6.65 for Q2 2026 at Medline, down from 7.39 in the prior quarter.
- Over five years, Price to Sales peaked at 7.39 in Q1 2026 and troughed at 6.65 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Becton Dickinson | 49.84 Bn | 48.98 Bn | 2.32 Bn |
| 2 | Medline | 29.28 Bn | 26.61 Bn | 2.22 Bn |
| 3 | West Pharmaceutical Services | 24.04 Bn | 23.61 Bn | 329.20 Mn |
| 4 | Baxter International | 12.83 Bn | 10.68 Bn | 1.03 Bn |
| 5 | Stevanato Group S.p.A | 5.54 Bn | 5.43 Bn | 100.91 Mn |
| 6 | Acme United | 234.28 Mn | 229.24 Mn | 26.69 Mn |
| 7 | Rockwell Medical | 28.82 Mn | 4.02 Mn | 3.24 Mn |
| 8 | Retractable Technologies | 20.96 Mn | -18.91 Mn | 190,852.00 |
| 9 | United Health Products | 9.59 Mn | 9.56 Mn | - |
| 10 | Cuprina Holdings (Cayman) | 8.14 Mn | 5.02 Mn | - |